| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439553 | European Journal of Cancer | 2018 | 9 Pages |
Abstract
In conclusion, adjuvant ZOL reduced the risk of clinical fractures, the majority of this protection occurred after disease recurrence.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
C. Wilson, R. Bell, S. Hinsley, H. Marshall, J. Brown, D. Cameron, D. Dodwell, R. Coleman,